PremiumCompany AnnouncementsLivaNova Faces Legal Dispute Over Environmental Liabilities MongoDB and Asana downgraded: Wall Street’s top analyst calls Bullish Outlook for LivaNova: Growth in Cardiopulmonary and Epilepsy Segments with Promising Pipeline PremiumThe FlyLivaNova price target lowered to $55 from $56 at Barclays LivaNova PLC Reports Strong Q1 2025 Results LivaNova’s Strong Q1 2025 Performance and Positive Outlook Justify Buy Rating PremiumThe FlyLivaNova price target lowered to $50 from $60 at Mizuho Enovis names Damien McDonald as CEO, succeeding Matt Trerotola LivaNova’s Reduced Liability and Strong Cash Position Justify Buy Rating 
